Aclaris Therapeutics, Inc.
ACRS
$1.75
-$0.06-3.32%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 99.81M | 105.31M | 113.59M | 127.72M | 111.09M |
| Total Receivables | 194.00K | 250.00K | 8.92M | 343.00K | 325.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.20M | 3.23M | 3.44M | 4.27M | 6.22M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 104.20M | 108.79M | 125.95M | 132.33M | 117.64M |
|
|
|||||
| Total Current Assets | 104.20M | 108.79M | 125.95M | 132.33M | 117.64M |
| Net Property, Plant & Equipment | 3.44M | 3.65M | 3.85M | 4.11M | 4.40M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 424.00K | 444.00K | 224.00K | 243.00K | 262.00K |
| Total Assets | 189.15M | 198.09M | 220.33M | 182.39M | 161.07M |
|
|
|||||
| Total Accounts Payable | 8.80M | 6.35M | 4.69M | 7.66M | 7.27M |
| Total Accrued Expenses | 4.85M | 4.58M | 7.60M | 3.14M | 3.40M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 515.00K | 498.00K | 481.00K | 465.00K | 449.00K |
| Total Finance Division Other Current Liabilities | 12.68M | 10.08M | 18.83M | 7.55M | 4.56M |
| Total Other Current Liabilities | 12.68M | 10.08M | 18.83M | 7.55M | 4.56M |
| Total Current Liabilities | 26.84M | 21.51M | 31.60M | 18.82M | 15.68M |
|
|
|||||
| Total Current Liabilities | 26.84M | 21.51M | 31.60M | 18.82M | 15.68M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.85M | 1.99M | 2.12M | 2.25M | 2.37M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 28.72M | 30.53M | 31.06M | 31.18M | 9.20M |
| Total Liabilities | 57.41M | 54.03M | 64.77M | 52.24M | 27.25M |
|
|
|||||
| Common Stock & APIC | 1.06B | 1.06B | 1.06B | 936.03M | 933.01M |
| Retained Earnings | -933.38M | -917.95M | -902.86M | -806.31M | -798.72M |
| Treasury Stock & Other | 482.00K | 434.00K | 97.00K | 427.00K | -463.00K |
| Total Common Equity | 131.74M | 144.07M | 155.55M | 130.15M | 133.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 131.74M | 144.07M | 155.55M | 130.15M | 133.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 131.74M | 144.07M | 155.55M | 130.15M | 133.82M |
|
|
|||||